Clinical trial
Effects of Amlodipine in the Management of Chronic Heart Failure
NCT00151619 · Rennes University Hospital, Other · Terminated
Key facts
| NCT number | NCT00151619 |
|---|---|
| Title | Effects of Amlodipine in the Management of Chronic Heart Failure |
| Official title | Regional and Systemic Hemodynamic Effects of a Long-term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin |
| Lead sponsor | Rennes University Hospital, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Heart Failure |
| Intervention type | Drug |
| Interventions | Amlodipine |
| Enrollment | 7 |
| Start date | Feb 10, 1999 |
| Primary completion | Sep 6, 2001 |
| First posted | Sep 9, 2005 |
| Last update posted | Mar 26, 2019 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: